New aspects in Peyronie's disease - A mini-review

Andrologia

Volumn 31, Issue SUPPL. 1, 1999, Pages 31-35

  Schroeder Printzen, I ^a   Hauck, Ekkehard W ^a   Weidner, W ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Aetiopathogenesis; Diagnostic work up; Drug therapy; Peyronie's disease; Surgical procedures

Indexed keywords

4 AMINOBENZOATE POTASSIUM; ALPHA2 INTERFERON; TAMOXIFEN; VERAPAMIL;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERECTILE DYSFUNCTION; EXTRACORPOREAL LITHOTRIPSY; HUMAN; IMPOTENCE; IONTOPHORESIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATHOGENESIS; PENIS DISEASE; PEYRONIE DISEASE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0033405661     PISSN: 03034569     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0272.1999.tb01448.x     Document Type: Conference Paper

References (28)

1. Ahuja SK, Case J, Vincent M, Sikka SC, Hellstrom WJ (1998) Intralesional injection of alpha interferon 2b in the treatment of Peyronie's disease. J Urol 159 (Suppl): 117.
2. Andresen R, Wegner HEH, Miller K, Banzer D (1998) Imaging modalities in Peyronie's disease. Eur Urol 34: 128-135.
3. Apaydin E, Semerci B, Kefi A, Cikili N, Gürsan A, Mülazimoglu N (1998) The use of tamoxifen in the treatment of Peyronie's disease. Int J Impot Res 10 (Suppl 3):57.
4. Baumann M, Tauber R (1998) Induratio penis plastica -Extrakorporale piezoelektrische Stoßwellentherapie (EPT) als neuer Therapieansatz. Akt Urol 29:1-5.
5. Brockelmann TJ, Limper AH, Colby TV, McDonald JA (1991) Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 88:6642.
6. Butz M, Teichert HM (1998) Treatment of Peyronie's disease by extracorporal shockwaves (ESW). J Urol 159 (Suppl): 118.
7. Castilla A, Prieto J, Fausto N (1991) Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy. New Engl J Med 324:933.
8. Colombo F, Serrago M, Esposito N, Patelli E, Mantrovani F, Pisani E (1998) Shock waves in La Peyronie's disease: the preliminary report. J Urol 159 (Suppl): 119.
9. Duncan MR, Berman B, Nseyo UO (1991) Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons alpha, beta and gamma. Scand J Urol Nephrol 141:81-94.
10. El-Sakka AI, Hassoba HM, Chui RM, Bhatnagar RS, Dahiya R, Lue TF (1997a) An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta m-RNA and protein expression. J Urol 158:2284-2290.
11. El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF (1997b) Peyronie's disease is associated with an increase of transforming growth factor-β protein expression. J Urol 158:1391-1394.
12. El-Sakka AI, Selph CA, Yen TSB, Dahiya R, Lue TF (1998) The effect of surgical trauma on rat tunica albuginea. J Urol 159:1700-1707.
13. Heitz M, Pottek T, Olianas R, Schreiter F (1998) Small incision dermalgraft corporoplasty to treat severe penile deviation due to Peyronie's disease. J Urol 159 (Suppl): 118.
14. Jarow JP, Lowe FC (1997) Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction. J Urol 158:1388-1390.
15. Judge JS, Wisniewski ZS (1997) Intralesional Interferon in the treatment of Peyronie's disease: a pilot study. Br J Urol 79:40-42.
16. Levine LA (1997) Treatment of Peyronie's disease with intralesional Verapamil injection. J Urol 158:1395-1399.
17. Lue TF, Rashwan HM, El-Sakka AI (1998) Outcome analysis of correcting penile deformity with incision and venous grafting. Urol 159 (Suppl):117.
18. Nicolai M, Cipollone G, Iantorno R, Zezza GMA, Tenaglia R (1998) Intralesional Verapramil injection versus placebo in Peyronie's disease. J Urol 159 (Suppl):117.
19. Polat Ö, Gül O, Özbey I, Özdikici M, Bayraktar Y (1997) Peyronie's disease: Intralesional treatment with interferon alpha-2a and evaluation of the results by magnetic resonance imaging. Int Urol Nephrol 29:465-471.
20. Ralph DJ, Bettocchi C, Pryor JP (1998) Plaque incision and vein patching for Peyronie's disease: the Lue procedure. Int J Impot Res 10 (Suppl 3):39.
21. Rehman J, Benet A, Melman A (1998) Use of Intralesional Verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. Urology 51:620-626.
22. Riedl CR, Plas E, Engelhard P, Pflüger H (1998) Iontophoresis for the treatment of Peyronie's disease. J Urol 159 (Suppl):117.
23. Telöken C, da Ros C, Graziottin T, Rhoden E, Sogari P, Souto C (1998) The use of tamoxifen in Peyronie's disease. Int J Impot Res 10 (Suppl 3):63.
24. Treffiletti S, Annoscia S, Montefiore F, Boccafoschi C (1997) Iontophoresis in the conservative treatment of Peyronie's disease: preliminary experience. Arch Ital Urol Androl 69:323-327.
25. Vosshenrich R, Schroeder-Printzen I, Weidner W, Fischer U, Funke M, Ringert RH (1995) Value of magnetic resonance imaging in patients with penile induration (Peyronie's disease). J Urol 153:1122-1125.
26. Wegner HEH, Andresen R, Knispel HH, Miller K (1997) Local interferon-alpha2b is not an effective treatment in early-stage Peyronie's disease. Eur Urol 32:190-193.
27. Weidner W, Schroeder-Printzen I, Rudnick J, Weiske WH, Krause W, Aulitzky W, Drawz B, Rebmann U, Pastarmadjeff L, Kallerhoff M, Lenk S, Schnitker J (1996) Randomized placebocontrolled therapy of Peyronie's disease (IPP) with Potaba®. Eur Urol 30 (Suppl 2):847.
28. Weidner W, Schroeder-Printzen I, Weiske WH, Vosshenrich R (1997) Sexual dysfunction in Peyronie's disease: an analysis of 222 patients without previous local plaque therapy. J Urol 157:325-328.